Syngene's MD & CEO On Q4 Report Card & FY24 Focus Areas

  • last year
Good growth momentum on R&D and manufacturing helps Syngene fuel 'better than expected' Q4 earnings. MD & CEO Jonathan Hunt shares projections for FY24.

Recommended